Physician profile
Paul P Szotek
NPI 1649437922
$2,382,860.52
in general payments reported to CMS, 2019-2025
8 companies · $354K in 2025
The $354K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $148K · 2020: $104K · 2021: $389K · 2022: $504K · 2023: $521K · 2024: $362K · 2025: $354K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1.1M · Travel and Lodging: $92K · Food and Beverage: $15K · Education: $108 · Entertainment: $15.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,130,149.54 |
| Travel and Lodging | $92,300.16 |
| Food and Beverage | $15,258.04 |
| Education | $107.96 |
| Entertainment | $15.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $2,363,082.91 | 2019-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Covidien Lp | $18,225.00 | 2020 | |
| Abbvie INC. | $600.00 | 2022 | |
| Tas Medical, INC. | $422.12 | 2024 | |
| Intuitive Surgical, INC. | $233.12 | 2020-2023 | Da Vinci Surgical System |
| Conmed Corporation | $223.30 | 2022-2024 | Airseal |
| Allergan, INC. | $51.85 | 2019 | |
| Biotissue Holdings INC. | $22.22 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Szotek listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.